Suchergebnisse - "Taub, Jeffrey W"

PubPharm (10)

1

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

enthalten in: Cancer research | 2024

von Su, Y. | Carter, J. | Li, X. | +31

2

Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia : In vitro models and mechanisms

enthalten in: Biochemical pharmacology | 2023

von Carter, J. | Su, Y. | Qiao, X. | +10

3

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia

enthalten in: Apoptosis : an international journal on programmed cell death | 2022

von Liu, S. | Qiao, X. | Wu, S. | +8

4

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

enthalten in: Cells | 2022

von Wu, S. | Edwards, H. | Wang, D. | +7

5

Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Signal transduction and targeted therapy | 2020

von Luedtke, D. | Su, Y. | Ma, J. | +10

6

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Ma, J. | Zhao, S. | Qiao, X. | +12

CommentIn: Clin Cancer Res. 2019 Nov 15;25(22):6567-6569. - PMID 31515455

7

Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo

enthalten in: Targeted oncology | 2019

von Liu, F. | Knight, T. | Su, Y. | +7

8

Inhibition of XPO1 enhances cell death induced by ABT-199 in acute myeloid leukaemia via Mcl-1

enthalten in: Journal of cellular and molecular medicine | 2018

von Luedtke, D. | Su, Y. | Liu, S. | +5

9

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2016

von Niu, X. | Zhao, J. | Ma, J. | +11

10

Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells

enthalten in: Oncotarget | 2016

von Zhao, J. | Niu, X. | Li, X. | +6

1
[1]